IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    How to prepare for the chance of injury and illness on trips

    04:44
  • Start TODAY’s June 2023 walking challenge: What to know

    05:02
  • 5 reasons to join Start TODAY walking challenge

    05:04
  • Former NFL player tackles mental health in Black community

    04:29
  • Ticks, heat rash, hydration and more: How to enjoy summer safely

    04:42
  • Author and podcast host Case Kenny talks mindfulness journey

    04:18
  • Tips and techniques to build confidence

    04:35
  • Jillian Michaels talks injury, demonstrates 3 exercises for longevity

    04:43
  • Salmonella outbreak in 6 states linked to raw cookie dough

    00:29
  • Multivitamins may help slow age-related memory loss, study shows

    02:39
  • Sunblock, sunscreen, SPF: How to choose the right sun protection

    04:25
  • Twins turn tragedy into lifetime dedicated to neurologic research

    05:05
  • Dylan Dreyer opens up about son Calvin’s celiac disease diagnosis

    06:58
  • Did Ozempic tap into a potential addiction cure?

    05:43
  • Ally Love shares healthy habits to bring wellness into your mornings

    06:10
  • Allergy treatment options: Which one is right for you?

    04:50
  • TODAY's Al Roker shares pic of new knee following surgery

    03:52
  • What should you stock in your medicine cabinet? Best OTC picks

    03:43
  • Peloton's Ally Love joins TODAY show as a contributor

    06:45
  • Surgeon General warns of social media danger to mental health

    03:08

Johnson & Johnson CEO announces vaccine candidate with high degree of probability

05:45

Alex Gorsky, chairman and CEO of Johnson & Johnson, one of several companies that’s developed a potential coronavirus vaccine, tells TODAY that his company has a candidate “that has a high degree of probability of being successful.” He anticipates starting tests in humans in September and says “We could have vaccines ready in Q1 and Q2 of 2021.”